Occult prostate cancer in men with low serum testosterone levels.
Occult prostate cancer in men with low serum testosterone levels.
复制标题
血清睾酮水平低的男性患有隐匿性前列腺癌。
DOI:
10.1001/jama.1996.03540230054035
复制
发表时间:
1996
期刊:
影响因子:
--
通讯作者:
W. DeWolf
中科院分区:
文献类型:
--
作者:
A. Morgentaler;C. Bruning;W. DeWolf
OBJECTIVE
To determine the prevalence of occult prostate cancer in men with low serum total testosterone or free testosterone levels.
DESIGN
Retrospective analysis of a consecutive series of men.
SETTING
Academic teaching hospital.
PATIENTS
Seventy-seven men with low total testosterone or free testosterone levels, with normal results of digital rectal examination and prostate-specific antigen (PSA) levels of 4.0 ng/mL or less. The mean age was 58 years.
INTERVENTIONS
Sextant prostate needle biopsies with ultrasound guidance.
MAIN OUTCOME MEASURES
Results of prostate needle biopsies, transrectal ultrasound, prostate volume, PSA level, PSA density, total and free testosterone levels.
RESULTS
Prostate cancer was identified in 14% (11/77) of the entire group and in 10 men (29%) aged 60 years or older. The median age for men with cancer was 64 years. Histologic examination showed Gleason scores of 6 or 7 for all cancers. No significant differences were noted between the cancer and benign groups with regard to PSA level, PSA density, prostate volume, total testosterone level, or free testosterone level.
CONCLUSIONS
A high prevalence of biopsy-detectable prostate cancer was identified in men with low total or free testosterone levels despite normal PSA levels and results of digital rectal examination. These data suggest that (1) digital rectal examination and PSA levels are insensitive indicators of prostate cancer in men with low total or free testosterone levels, and (2) PSA levels may be altered by naturally occurring reductions in serum androgen levels.